This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2021 Jul 1;137(26):3682-3684.

doi: 10.1182/blood.2020010177.

Therapeutic options in VEXAS syndrome: insights from a retrospective series

Affiliations

Affiliations

¹ Service d'Hématologie Biologique and.
² Service d'Hématologie Clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France.
³ Service de Médecine Interne, Hospices Civils de Lyon-Hôpital de la Croix Rousse, Lyon, France.
⁴ Service de Médecine Interne Hospices Civils de Lyon. Hôpital Edouard Herriot, Lyon, France; and.
⁵ Service de Médecine Interne, Hospices Civils de Lyon, Hôpital Lyon Sud, and.
⁶ Equipe Evaluation et Modélisations des Effets Thérapeutiques, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5588, Université Lyon 1, Lyon, France.

PMID: 33619558
DOI: 10.1182/blood.2020010177

Free article

Review

Therapeutic options in VEXAS syndrome: insights from a retrospective series

Estelle Bourbon et al. Blood. 2021.

Free article

. 2021 Jul 1;137(26):3682-3684.

doi: 10.1182/blood.2020010177.

Authors

Affiliations

¹ Service d'Hématologie Biologique and.
² Service d'Hématologie Clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France.
³ Service de Médecine Interne, Hospices Civils de Lyon-Hôpital de la Croix Rousse, Lyon, France.
⁴ Service de Médecine Interne Hospices Civils de Lyon. Hôpital Edouard Herriot, Lyon, France; and.
⁵ Service de Médecine Interne, Hospices Civils de Lyon, Hôpital Lyon Sud, and.
⁶ Equipe Evaluation et Modélisations des Effets Thérapeutiques, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 5588, Université Lyon 1, Lyon, France.

PMID: 33619558
DOI: 10.1182/blood.2020010177

No abstract available

PubMed Disclaimer

Similar articles

VEXAS syndrome.
Grayson PC, Patel BA, Young NS. Grayson PC, et al. Blood. 2021 Jul 1;137(26):3591-3594. doi: 10.1182/blood.2021011455. Blood. 2021. PMID: 33971000 Free PMC article. Review.
VEXAS: a vivid new syndrome associated with vacuoles in various hematopoietic cells.
Lytle A, Bagg A. Lytle A, et al. Blood. 2021 Jul 1;137(26):3690. doi: 10.1182/blood.2021010714. Blood. 2021. PMID: 34196684 No abstract available.
A case of VEXAS syndrome with subtle morphologic findings.
Horton RK, Zheng G. Horton RK, et al. Blood. 2021 Oct 14;138(15):1378. doi: 10.1182/blood.2021012596. Blood. 2021. PMID: 34647982 No abstract available.
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies.
Gurnari C, Pagliuca S, Durkin L, Terkawi L, Awada H, Kongkiatkamon S, Zawit M, Hsi ED, Carraway HE, Rogers HJ, Visconte V, Maciejewski JP. Gurnari C, et al. Blood. 2021 Jul 1;137(26):3685-3689. doi: 10.1182/blood.2021010811. Blood. 2021. PMID: 33690844 Free PMC article.
Thrombotic manifestations of VEXAS syndrome.
Groarke EM, Dulau-Florea AE, Kanthi Y. Groarke EM, et al. Semin Hematol. 2021 Oct;58(4):230-238. doi: 10.1053/j.seminhematol.2021.10.006. Epub 2021 Oct 25. Semin Hematol. 2021. PMID: 34802545 Review.

See all similar articles

Cited by

Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome.
Dias AL, Groarke EM, Hickstein D, Patel B. Dias AL, et al. Ann Hematol. 2024 Nov;103(11):4427-4436. doi: 10.1007/s00277-024-05942-2. Epub 2024 Aug 22. Ann Hematol. 2024. PMID: 39168911 Free PMC article. Review.
Case report of a patient with VEXAS syndrome.
Tsourveloudis I, Georgiadi EC, Vatalis G, Kotsi P. Tsourveloudis I, et al. Medicine (Baltimore). 2023 Dec 29;102(52):e36738. doi: 10.1097/MD.0000000000036738. Medicine (Baltimore). 2023. PMID: 38206689 Free PMC article.
Immune-dysregulation harnessing in myeloid neoplasms.
Sharifi MJ, Xu L, Nasiri N, Ashja-Arvan M, Soleimanzadeh H, Ganjalikhani-Hakemi M. Sharifi MJ, et al. Cancer Med. 2024 Sep;13(17):e70152. doi: 10.1002/cam4.70152. Cancer Med. 2024. PMID: 39254117 Free PMC article. Review.
Extensive reactive cutaneous histiocytic infiltrate resembling non-Langerhans cell histiocytosis as the presenting sign of underlying vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome.
Wang CX, Yokoyama CC, Rosman IS, Musiek AC. Wang CX, et al. JAAD Case Rep. 2023 Nov 21;43:20-23. doi: 10.1016/j.jdcr.2023.11.008. eCollection 2024 Jan. JAAD Case Rep. 2023. PMID: 38162410 Free PMC article. No abstract available.
Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
Padureanu V, Marinaș CM, Bobirca A, Padureanu R, Patrascu S, Dascalu AM, Bobirca F, Tribus L, Alexandru C, Serboiu C, Dumitrascu C, Musetescu A. Padureanu V, et al. Cureus. 2024 Jan 27;16(1):e53041. doi: 10.7759/cureus.53041. eCollection 2024 Jan. Cureus. 2024. PMID: 38410307 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal